

A killer acquisition is a transaction where a large or dominant company acquires a smaller innovative company primarily to remove a future competitive threat, slow down innovation, or discontinue a product that could challenge its existing business.
Not every startup acquisition is a killer acquisition. Many acquisitions help startups scale faster, access distribution, or improve products. The concern arises when the purpose or effect of the acquisition is to prevent a promising rival from growing.
Killer acquisitions usually involve a powerful incumbent acquiring a nascent competitor before the target becomes large enough to trigger traditional competition concerns.
Possible patterns include:
• Buying a startup with a product that could replace or weaken the acquirer's core product
• Shutting down or delaying the acquired product after the deal
• Absorbing the team but discontinuing the innovation
• Acquiring data, technology, or patents to prevent others from using them
• Using the acquisition to block future market entry or reduce investor confidence in rivals
These transactions are difficult to assess because the competitive threat is often future-facing, uncertain, and not fully visible in current revenue numbers.
Killer acquisitions are discussed most often in digital markets, pharma, biotechnology, platform businesses, artificial intelligence, fintech, and other innovation-led sectors. In these markets, a small company may not have high revenue yet but may still represent a serious future competitive threat.
Competition authorities around the world have become more interested in nascent competitor acquisitions because traditional merger thresholds based only on turnover may miss deals where the target has low revenue but high strategic value.
For founders, killer acquisition debates influence exit strategy, investor expectations, and regulatory scrutiny. For large companies, acquiring innovative startups may require stronger documentation of business rationale, consumer benefits, and post-acquisition plans. For policymakers, the challenge is to stop anti-competitive acquisitions without discouraging healthy startup exits.
Businesses should consider:
• Is the target a current or potential competitor?
• Will the acquired product continue to be developed?
• Does the deal reduce future innovation or customer choice?
• Are claimed efficiencies specific, credible, and measurable?
• Could the transaction attract merger-control review even if the target is small?